Blood Substitutes Struggle in Sea of Toxicity Concerns

Although blood shortages are common in much of the developing world and industrialized nations alike, the few players in the blood substitute market have much work to do to achieve success in that space. And it doesn't help that recent events threatened to send companies like Biopure Corporation, Hemosol BioPharma Inc. and Northfield Laboratories Inc. back to the starting block. (BioWorld Financial Watch)